SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adults
Open Access
- 23 August 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Abstract
As intrinsic differences in humoral immune response to SARS-CoV-2 between children and adults remain unclear, we improved characterisation by defining the kinetics, specificity and function of antibodies to SARS-CoV-2 in children (n = 146, aged 9.4 ± 4.8 years with n = 257 samples) compared to adults (n = 85, aged 39.5 ± 15.2 years with n = 122 samples). We used plasma samples from an infection and vaccination-naive cohort study with RT-PCR confirmed ancestral B.1* SARS-CoV-2 virus infection with asymptomatic or mild disease, collected in Hong Kong between March to December 2020, from acute (0–14 days post infection) to convalescent (15–206 days) timepoints. Children had significantly lower primary antibody responses against SARS-CoV-2 proteins overall, leading to a less isotype switched response. While children had lower OC43 Spike and SARS-CoV-2 S2 IgG and avidity than adults, they exhibited higher avidities for SARS-CoV-2 whole Spike and Nucleocapsid, and higher levels of Spike FcγR-binding antibodies. Adults’ SARS-CoV-2 antibody responses could be derived from high avidity pre-existing cross-reactive common cold coronavirus B cell responses, whilst children appear to generate a de novo SARS-CoV-2- specific Spike and Nucleocapsid IgG with robust Fc receptor (FcR) binding ability and high avidity at a higher proportion than adults, thus their responses are more targeted and functional for SARS-CoV-2.Keywords
Funding Information
- Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (COVID190126 and 190115)
- Foundation for the National Institutes of Health (HHSN272201400006C)
- Theme based Research Grants Scheme
This publication has 65 references indexed in Scilit:
- Elucidating systemic immune responses to acute and convalescent SARS‐CoV‐2 infection in children and elderly individualsImmunity, Inflammation and Disease, 2024
- Primary SARS‐CoV‐2 infection in children and adults results in similar Fc‐mediated antibody effector function patternsClinical & Translational Immunology, 2024
- Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipientsEuropean Journal of Immunology, 2022
- WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity ScalesJournal of General Internal Medicine, 2022
- Comparison of Seroconversion in Children and Adults With Mild COVID-19JAMA Network Open, 2022
- Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community SettingJAMA Pediatrics, 2021
- Association of Age With SARS-CoV-2 Antibody ResponseJAMA Network Open, 2021
- Production of ORF8 protein from SARS-CoV-2 using an inducible virus-mediated expression system in suspension-cultured tobacco BY-2 cellsPlant Cell Reports, 2021
- Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implicationsEuropean Journal of Epidemiology, 2020
- Data Analysis2016